Continuous versus intermittent infusion of cefepime in neurosurgical patients with post-operative intracranial infections

Int J Antimicrob Agents. 2014 Jan;43(1):68-72. doi: 10.1016/j.ijantimicag.2013.08.019. Epub 2013 Oct 1.

Abstract

Cefepime is administered as an intermittent infusion (II); however, continuous infusion (CI) may be advantageous because β-lactam antibiotics exhibit time-dependent antibacterial activity. This retrospective, non-randomised, comparative study included 68 neurosurgical patients with post-operative intracranial infections treated with 4g/day cefepime over 24h as a CI (n=34) or 2g every 12h as II (n=34). CI controlled the intracranial infection more rapidly and effectively than II (6.6±1.9 days vs. 7.8±2.6 days; P=0.036). By considering the minimum inhibitory concentrations (MICs) to be 4μg/mL and 8μg/mL, the percentage of time when the cefepime plasma or CSF concentrations were higher than the MIC (%T>MIC) was calculated for each patient. For plasma cefepime concentrations, the %T(>MIC) in the CI group was higher than in the II group (for MICs of 8μg/mL, 100% vs. 75%, respectively). The mean calculated area under the curve (AUC) in the CI group was similar to the II group (1197.99±72.15μgh/mL vs. 890.84±140.78μgh/mL; P=0.655). For CSF cefepime concentrations, the %T(>MIC) in the CI group was higher than in the II group (for MICs of 4μg/mL and 8μg/mL, 83.3% and 75% vs. 25% and 0%, respectively). The mean calculated AUC for the CI group was higher than the II group (220.56±13.59μgh/mL vs. 86.34±5.69μgh/mL; P=0.003). Therefore, CI of cefepime significantly enhanced the antibacterial effect and reduced the treatment duration in neurosurgical patients with post-operative intracranial infections.

Keywords: Cefepime; Continuous infusion; Intermittent infusion; Intracranial infection; Minimum inhibitory concentration.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / pharmacokinetics*
  • Cefepime
  • Cephalosporins / administration & dosage*
  • Cephalosporins / pharmacokinetics*
  • Female
  • Humans
  • Infusions, Intravenous / methods
  • Male
  • Meningitis, Bacterial / drug therapy*
  • Middle Aged
  • Neurosurgical Procedures / adverse effects
  • Plasma / chemistry
  • Postoperative Complications / drug therapy*
  • Retrospective Studies

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Cefepime